| 
                    Name | 
                         3alpha-hydroxy-3,5-dihydromonacolin L acid 
                     | 
                
| Molecular Formula | C19H32O5 | |
| IUPAC Name* | 
                         (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid 
                     | 
                |
| SMILES | 
                         C[C@@H]1CC[C@@H]2[C@H]([C@H]([C@@H](C=C2C1)O)C)CC[C@H](C[C@H](CC(=O)O)O)O 
                     | 
                |
| InChI | 
                         InChI=1S/C19H32O5/c1-11-3-5-17-13(7-11)8-18(22)12(2)16(17)6-4-14(20)9-15(21)10-19(23)24/h8,11-12,14-18,20-22H,3-7,9-10H2,1-2H3,(H,23,24)/t11-,12-,14-,15-,16+,17+,18-/m1/s1 
                     | 
                |
| InChIKey | 
                         MRKCPMGQBNMKTA-GBRHIFDWSA-N 
                     | 
                |
| Synonyms | 
                         3alpha-hydroxy-3,5-dihydromonacolin L acid; 113855-37-1; 3alpha-Hydroxy-3,5-dihydromonacolin L; 3-Hydroxy-3,5-dihydromonacolin L; 3-ADML; (3r,5r)-3,5-dihydroxy-7-[(1r,2r,3s,6r,8ar)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]heptanoic acid; (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoic acid; CHEBI:82972; DTXSID00921221; C20852; Q27156514; (3R,5R)-7-[(1R,2R,3S,6R,8aR)-3-Hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl]-3,5-dihydroxyheptanoate; (3R,5R)-7-[[(1R)-1,2,3,5,6,7,8,8abeta-Octahydro-3alpha-hydroxy-2beta,6alpha-dimethylnaphthalen]-1beta-yl]-3,5-dihydroxyheptanoic acid; 3,5-dihydroxy-7-(3-hydroxy-2,6-dimethyl-1,2,3,5,6,7,8,8a-octahydronaphthalen-1-yl)heptanoic acid 
                     | 
                |
| CAS | 113855-37-1 | |
| PubChem CID | 195046 | |
| ChEMBL ID | NA | 
Chemical Classification: | 
                    
                        
  | 
                    
                        
                            
                     | 
                
|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | |
|---|---|---|---|---|---|---|---|---|
| Endophyte ID | Endophyte Name | Family | Genus | Taxonomy ID | GenBank ID | Closest GenBank ID | Reference | 
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Bioactivity Name | Target ID | Target Name | Target Type | Target Organism | Target Organism ID | Potency of Bioactivity | Activity Type | Value | Unit | Endophyte ID | Endophyte Name | 
| Molecular Weight: | 340.5 | ALogp: | 1.9 | 
| HBD: | 4 | HBA: | 5 | 
| Rotatable Bonds: | 7 | Lipinski's rule of five: | Accepted | 
| Polar Surface Area: | 98.0 | Aromatic Rings: | 2 | 
| Heavy Atoms: | 24 | QED Weighted: | 0.534 | 
| Caco-2 Permeability: | -5.607 | MDCK Permeability: | 0.00004440 | 
| Pgp-inhibitor: | 0.001 | Pgp-substrate: | 0.999 | 
| Human Intestinal Absorption (HIA): | 0.064 | 20% Bioavailability (F20%): | 0.891 | 
| 30% Bioavailability (F30%): | 0.985 | 
| Blood-Brain-Barrier Penetration (BBB): | 0.095 | Plasma Protein Binding (PPB): | 82.83% | 
| Volume Distribution (VD): | 0.393 | Fu: | 10.08% | 
| CYP1A2-inhibitor: | 0.022 | CYP1A2-substrate: | 0.104 | 
| CYP2C19-inhibitor: | 0.015 | CYP2C19-substrate: | 0.832 | 
| CYP2C9-inhibitor: | 0.015 | CYP2C9-substrate: | 0.969 | 
| CYP2D6-inhibitor: | 0.003 | CYP2D6-substrate: | 0.092 | 
| CYP3A4-inhibitor: | 0.012 | CYP3A4-substrate: | 0.109 | 
| Clearance (CL): | 7.243 | Half-life (T1/2): | 0.904 | 
| hERG Blockers: | 0.015 | Human Hepatotoxicity (H-HT): | 0.611 | 
| Drug-inuced Liver Injury (DILI): | 0.556 | AMES Toxicity: | 0.005 | 
| Rat Oral Acute Toxicity: | 0.294 | Maximum Recommended Daily Dose: | 0.973 | 
| Skin Sensitization: | 0.184 | Carcinogencity: | 0.277 | 
| Eye Corrosion: | 0.004 | Eye Irritation: | 0.186 | 
| Respiratory Toxicity: | 0.894 | 
| Similar NPs | Similar Drugs | ||||||
|---|---|---|---|---|---|---|---|
| NPs ID | NPs 2D Structure | Similarity Score | TTD ID | Drug 2D Structure | Similarity Score | ||
| ENC006008 | ![]()  | 
                    0.472 | D02RQU | ![]()  | 
                    0.431 | ||
| ENC001102 | ![]()  | 
                    0.412 | D01WUA | ![]()  | 
                    0.286 | ||
| ENC006006 | ![]()  | 
                    0.342 | D05ZTH | ![]()  | 
                    0.245 | ||
| ENC002332 | ![]()  | 
                    0.270 | D0C6NM | ![]()  | 
                    0.236 | ||
| ENC004385 | ![]()  | 
                    0.269 | D0N3NO | ![]()  | 
                    0.230 | ||
| ENC004384 | ![]()  | 
                    0.269 | D06WTZ | ![]()  | 
                    0.229 | ||
| ENC004701 | ![]()  | 
                    0.256 | D0V0IX | ![]()  | 
                    0.227 | ||
| ENC005834 | ![]()  | 
                    0.255 | D0M4WA | ![]()  | 
                    0.225 | ||
| ENC004295 | ![]()  | 
                    0.248 | D0OR2L | ![]()  | 
                    0.220 | ||
| ENC005891 | ![]()  | 
                    0.242 | D0I4DQ | ![]()  | 
                    0.218 | ||